TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

THE INSIDES

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

THE INSIDES

ST13

US500000079294155

Classe

10, 42, 44

Pedido

79294155

Registro

6495567

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

06/12/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 42, 44

Data de depósito

16/07/2020

Data de registro

28/09/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/09/2021

Última transação

06/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

NZ

Examinador

FALK,JONATHAN ROBERT

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

THE INSIDES COMPANY LIMITED

Representantes

Molly Buck Richard Richard Law Group

Classificação técnica

Classes Nice

Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Surgical apparatus and instruments and medical apparatus and instruments for use in surgery; surgical devices for use in drug delivery, namely syringes, hypodermic needles, catheters and cannulas for use in drug delivery; external and implantable medical devices, namely prosthetic devices in the nature of artificial gastrointestinal implants, diagnostic medical devices for diagnosing gastrointestinal disorders and diseases, and devices to control the fluid in and out of stoma; Medical instruments, devices and apparatus for use in diagnostic testing of the gastrointestinal tract; medical devices for use in treating or diagnosing functional gastrointestinal disorders; gastrointestinal implants composed of artificial materials; medical instruments for delivery and retrieval of gastrointestinal implants; medical apparatus, namely, systems for delivery and retrieval of gastrointestinal implants; surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases; surgical implants comprised of artificial materials; surgical instruments and apparatus; medical instruments for interstitial thermotherapy of biological tissue; prosthetic artificial gastrointestinal implants and implants for use in urostomies; medical implants comprised of artificial materials; intravascular implants made from artificial materials; medical devices for placing and securing catheters; catheters; medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas, high output ileostomies, high output fistulas; medical devices to assist in trans-anal surgery; medical devices for intestinal re-feeding; medical devices for intestinal drug deployment, sold empty; medical devices for use in treating or diagnosing gastrointestinal disease

Classe 42

Providing a platform-as-a-service (PaaS) featuring computer software platforms to enable patients and health care providers to interact remotely, health care providers to access and manage patient medical data, patients to receive information and advertising related to their health care, and patients and clinicians to purchase health care products, for digital health care purposes; and medical research services and scientific laboratory services for acquiring, testing and screening data within the framework of continuous health monitoring

Classe 44

Medical services and surgical services, namely gastrointestinal surgery, gynaecological surgery, colorectal surgery and endoscopies of the gastrointestinal tract; Medical and surgical diagnostic testing, monitoring and reporting services; fitting of prosthetics; medical diagnostic testing, monitoring and reporting services in the fields of medicine related to the gastrointestinal tract; DNA screening for medical purposes, namely, medical DNA and genetic testing for the diagnosis of conditions of the gastrointestinal tract; medical diagnostic testing and reporting services for conditions of the gastrointestinal tract; Collection of human cell or tissue samples for the medical diagnosis of conditions of the gastrointestinal tract; remote patient monitoring services to assist medical professionals in providing medical diagnosis and treatment; medical services, namely, monitoring of losses of intestinal fluid from enterostomies; medical services, namely, monitoring of patient adherence to intestinal re-feeding; medical services, namely, intestinal drug delivery services; medical services, namely, intestinal probiotic delivery services; medical services, namely, intestinal microbiome monitoring

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/09/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/09/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/09/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/04/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

16/03/2022

FIMP

FINAL DISPOSITION PROCESSED

16/03/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

28/12/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

28/09/2021

GPNX

NOTIFICATION PROCESSED BY IB

19/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/07/2021

PUBO

PUBLISHED FOR OPPOSITION

13/07/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

30/06/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

30/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

23/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/06/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/05/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

30/05/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

23/04/2021

GNFR

FINAL REFUSAL E-MAILED

23/04/2021

CNFR

FINAL REFUSAL WRITTEN

23/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2021

RFNT

REFUSAL PROCESSED BY IB

20/12/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/11/2020

RFRR

REFUSAL PROCESSED BY MPU

27/11/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/11/2020

CNRT

NON-FINAL ACTION WRITTEN

06/11/2020

DOCK

ASSIGNED TO EXAMINER

29/10/2020

MAFR

APPLICATION FILING RECEIPT MAILED

02/10/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/09/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

24/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace THE INSIDES ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.